Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Nurix Therapeutics (NRIX) Operating Expenses: 2019-2024

Historic Operating Expenses for Nurix Therapeutics (NRIX) over the last 6 years, with Nov 2024 value amounting to $267.6 million.

  • Nurix Therapeutics' Operating Expenses rose 47.74% to $99.3 million in Q3 2025 from the same period last year, while for Aug 2025 it was $350.9 million, marking a year-over-year increase of 40.29%. This contributed to the annual value of $267.6 million for FY2024, which is 15.31% up from last year.
  • According to the latest figures from FY2024, Nurix Therapeutics' Operating Expenses is $267.6 million, which was up 15.31% from $232.1 million recorded in FY2023.
  • In the past 5 years, Nurix Therapeutics' Operating Expenses registered a high of $267.6 million during FY2024, and its lowest value of $82.8 million during FY2020.
  • Its 3-year average for Operating Expenses is $240.7 million, with a median of $232.1 million in 2023.
  • Data for Nurix Therapeutics' Operating Expenses shows a peak YoY soared of 78.30% (in 2021) over the last 5 years.
  • Over the past 5 years, Nurix Therapeutics' Operating Expenses (Yearly) stood at $82.8 million in 2020, then soared by 78.30% to $147.6 million in 2021, then soared by 50.70% to $222.5 million in 2022, then increased by 4.29% to $232.1 million in 2023, then rose by 15.31% to $267.6 million in 2024.